Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Minerva Neurosciences Net Income 2013-2019 | NERV

Minerva Neurosciences net income from 2013 to 2019. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Minerva Neurosciences Annual Net Income
(Millions of US $)
2018 $-50
2017 $-32
2016 $-31
2015 $-27
2014 $-57
2013 $-3
2012 $-2
Minerva Neurosciences Quarterly Net Income
(Millions of US $)
Q1 2019 $-16
Q4 2018 $-13
Q3 2018 $-12
Q2 2018 $-13
Q1 2018 $-12
Q4 2017 $0
Q3 2017 $-11
Q2 2017 $-10
Q1 2017 $-11
Q4 2016 $-9
Q3 2016 $-8
Q2 2016 $-5
Q1 2016 $-8
Q4 2015 $-8
Q3 2015 $-6
Q2 2015 $-7
Q1 2015 $-6
Q4 2014 $-7
Q3 2014 $-27
Q2 2014 $-19
Q1 2014 $-3
Q4 2013 $0
Q3 2013 $-0
Q2 2013 $-0
Q4 2012 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.171B $0.000B
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. The Company's pipeline will initially target the treatment of schizophrenia, major depressive disorder (MDD), insomnia, and Parkinson's disease. Its product candidates include MIN-101, MIN-117, MIN-202 and MIN-301. Minerva Neurosciences, Inc. is based in Cambridge, MA, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $53.040B 33.89
Takeda Pharmaceutical (TAK) Japan $26.669B 7.83
Grifols (GRFS) Spain $13.442B 17.00
Sage Therapeutics (SAGE) United States $9.195B 0.00
Ionis Pharmaceuticals (IONS) United States $9.083B 19.86
Neurocrine Biosciences (NBIX) United States $7.853B 0.00
Catalent (CTLT) United States $7.369B 29.57
Jazz Pharmaceuticals (JAZZ) Ireland $7.311B 10.02
Nektar Therapeutics (NKTR) United States $5.874B 9.57
Tilray (TLRY) Canada $3.929B 0.00
FibroGen (FGEN) United States $3.705B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.481B 12.21
United Therapeutics (UTHR) United States $3.443B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.508B 377.86
PTC Therapeutics (PTCT) United States $2.359B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.061B 7.42
Portola Pharmaceuticals (PTLA) United States $1.848B 0.00
Xencor (XNCR) United States $1.834B 50.08
Tricida (TCDA) United States $1.821B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.767B 85.56
Enanta Pharmaceuticals (ENTA) United States $1.753B 23.96
Zogenix (ZGNX) United States $1.711B 0.00
USANA Health Sciences (USNA) United States $1.687B 14.66
Ironwood Pharmaceuticals (IRWD) United States $1.645B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.552B 0.00
Aerie Pharmaceuticals (AERI) United States $1.529B 0.00
Heron Therapeutics (HRTX) United States $1.446B 0.00
Esperion Therapeutics (ESPR) United States $1.381B 0.00
Turning Point Therapeutics (TPTX) United States $1.330B 0.00
Corcept Therapeutics (CORT) United States $1.191B 17.00
Radius Health (RDUS) United States $1.090B 0.00
ArQule (ARQL) United States $1.047B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.937B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.917B 0.00
Endo (ENDP) Ireland $0.884B 1.42
Odonate Therapeutics (ODT) United States $0.723B 0.00
Aptorum Group (APM) China $0.688B 0.00
CannTrust Holdings (CTST) Canada $0.683B 0.00
Organogenesis Holdings (ORGO) United States $0.676B 0.00
TherapeuticsMD (TXMD) United States $0.642B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.581B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.550B 0.00
Dermira (DERM) United States $0.532B 0.00
Akebia Therapeutics (AKBA) United States $0.522B 0.00
Translate Bio (TBIO) United States $0.513B 0.00
ChemoCentryx (CCXI) United States $0.510B 0.00
GlycoMimetics (GLYC) United States $0.484B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.459B 0.00
Siga Technologies (SIGA) United States $0.449B 1.06
Flexion Therapeutics (FLXN) United States $0.441B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.422B 21.29
BioCryst Pharmaceuticals (BCRX) United States $0.398B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.391B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.373B 0.00
Collegium Pharmaceutical (COLL) United States $0.372B 0.00
Karyopharm Therapeutics (KPTI) United States $0.365B 0.00
KalVista Pharmaceuticals (KALV) United States $0.358B 0.00
TCR2 Therapeutics (TCRR) United States $0.350B 0.00
Forty Seven (FTSV) United States $0.348B 0.00
ImmunoGen (IMGN) United States $0.323B 0.00
Rafael Holdings (RFL) United States $0.304B 0.00
CASI Pharmaceuticals (CASI) United States $0.300B 0.00
Harpoon Therapeutics (HARP) United States $0.292B 0.00
Xeris Pharmaceuticals (XERS) United States $0.281B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.280B 0.00
Molecular Templates (MTEM) United States $0.276B 0.00
OptiNose (OPTN) United States $0.272B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.268B 0.00
Concert Pharmaceuticals (CNCE) United States $0.262B 0.00
Dova Pharmaceuticals (DOVA) United States $0.254B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.239B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.233B 0.00
Aratana Therapeutics (PETX) United States $0.232B 0.00
Calithera Biosciences (CALA) United States $0.228B 0.00
Lannett Co Inc (LCI) United States $0.208B 2.02
Recro Pharma (REPH) United States $0.207B 0.00
Aclaris Therapeutics (ACRS) United States $0.202B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.193B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.185B 0.00
Aldeyra Therapeutics (ALDX) United States $0.183B 0.00
IMV INC (IMV) Canada $0.181B 0.00
Ocular Therapeutix (OCUL) United States $0.180B 0.00
Bio Blast Pharma (ENLV) Israel $0.180B 0.00
MEI Pharma (MEIP) United States $0.177B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.174B 0.00
Nature's Sunshine Products (NATR) United States $0.174B 56.38
Opexa Therapeutics (ACER) United States $0.171B 0.00
Galectin Therapeutics (GALT) United States $0.171B 0.00
Jounce Therapeutics (JNCE) United States $0.167B 0.00
Redhill Biopharma (RDHL) Israel $0.161B 0.00
Ardelyx (ARDX) United States $0.156B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.152B 0.00
Majesco Entertainment (PTE) United States $0.151B 0.00
Neon Therapeutics (NTGN) United States $0.141B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.132B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.119B 0.00
AgeX Therapeutics (AGE) United States $0.117B 0.00
Tyme Technologies (TYME) United States $0.116B 0.00
Aquestive Therapeutics (AQST) United States $0.114B 0.00
Champions Oncology (CSBR) United States $0.102B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.102B 0.00
MediWound (MDWD) Israel $0.102B 0.00
Iterum Therapeutics (ITRM) Ireland $0.099B 0.00
Avenue Therapeutics (ATXI) United States $0.098B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.096B 68.53
Natural Alternatives (NAII) United States $0.091B 9.14
Infinity Pharmaceuticals (INFI) United States $0.091B 0.00
Cardiome Pharma (CORV) Canada $0.089B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.088B 0.00
Capnia (SLNO) United States $0.088B 0.00
Mast Therapeutics (SVRA) United States $0.085B 0.00
Nivalis Therapeutics (ALPN) United States $0.084B 0.00
DURECT (DRRX) United States $0.083B 0.00
China SXT Pharmaceuticals (SXTC) China $0.081B 0.00
Adherex Technologies (FENC) United States $0.080B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.079B 0.00
Otonomy (OTIC) United States $0.077B 0.00
Genocea Biosciences (GNCA) United States $0.076B 0.00
Novan (NOVN) United States $0.071B 0.00
SCYNEXIS (SCYX) United States $0.070B 0.00
Neos Therapeutics (NEOS) United States $0.068B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.067B 0.00
ElectroCore (ECOR) United States $0.059B 0.00
CTI BioPharma (CTIC) United States $0.054B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.052B 0.00
Zafgen (ZFGN) United States $0.052B 0.00
ProNAi Therapeutics (SRRA) Canada $0.051B 0.00
KemPharm (KMPH) United States $0.048B 0.00
India Globalization Capital (IGC) United States $0.047B 0.00
AIT Therapeutics (AITB) Israel $0.047B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.043B 0.00
Lipocine (LPCN) United States $0.043B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
Bio-Path Holdings (BPTH) United States $0.040B 0.00
BioLineRx (BLRX) Israel $0.038B 0.00
ContraFect (CFRX) United States $0.037B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.036B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.033B 0.00
PharmAthene (ALT) United States $0.033B 0.00
IsoRay (ISR) United States $0.029B 0.00
Heat Biologics (HTBX) United States $0.026B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.026B 0.00
Citius Pharmaceuticals (CTXR) United States $0.024B 0.00
Melinta Therapeutics (MLNT) United States $0.023B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.022B 0.00
Biomerica (BMRA) United States $0.021B 0.00
Pain Therapeutics (SAVA) United States $0.020B 0.00
Onconova Therapeutics (ONTX) United States $0.020B 0.00
Regulus Therapeutics (RGLS) United States $0.020B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.019B 1.56
PRECISION THERAPEUTICS INC (POAI) United States $0.018B 0.00
NanoViricides (NNVC) United States $0.018B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
Achieve Life Sciences (ACHV) United States $0.017B 0.00
HANCOCK JAFFE (HJLI) United States $0.015B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.015B 0.00
ESSA Pharma (EPIX) Canada $0.014B 0.00
Shineco (TYHT) China $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
VAXART, INC (VXRT) United States $0.011B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 1.78
Ohr Pharmaceuticals (OHRP) United States $0.010B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Trillium Therapeutics (TRIL) Canada $0.009B 0.00
Jaguar Animal Health (JAGX) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.005B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00